Glaukos Corporation

GKOSNYSEHealthcare● Active

$124.85

$-0.15(-0.12%)

Market Cap$7.3B

P/E Ratio—

52W High$148.11

52W Low$73.16

Avg Volume888K

Open$124.18

Beta0.81

Cash on Hand Financials Revenue

Glaukos Corporation (GKOS) Cash on Hand — Cash & Short-Term Investments

Cash & cash equivalents plus short-term investments from the balance sheet, YoY change, and net cash vs debt context.

GKOS · cash on hand · updated Dec 31, 2025

Core cash position

as of Dec 31, 2025

Cash & Short-Term Investments (CCE + ST Investments)

$278.8M▼ -12.6% vs prior year

FY · as of Dec 31, 2025 · Reported in USD

Cash & Cash Equiv. (CCE)

$90.8M

cashAndCashEquivalents

Short-Term Investments

$187.9M

shortTermInvestments

YoY Change vs Prior Year

-12.6%

vs prior fiscal year

Latest Quarter

$276.7M

Q1 2026

Data Scope & Methodology

Cash on Hand = Cash & Cash Equivalents (CCE) + Short-Term Investments, as reported on the balance sheet (10-K/10-Q). Also referred to as cash reserves or cash position. Not free cash flow.

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · Reported in USD

Source: FMP /balance-sheet-statement · SEC 10-K / 10-Q · USDUpdated: December 31, 2025

Net cash vs debt

Cash vs Debt · Balance Sheet Health

Cash & ST Investments$278.8MCash on Hand

Total Debt$139.6MTotal Debt

Net Cash / Net Debt+$139.1MNet Cash Position

Cash vs Debt Ratio

Cash 67%Glaukos Corporation cash as % of market cap: 3.80%% · MCap $7BDebt 33%

Glaukos Corporation has a net cash position of $139.1M, holding more cash than debt.

Net Cash = Cash & ST Investments − Total Debt$278.8M − $139.6M = +$139.1M

Cash on hand history

annual cash on hand trend · Cash & Short-Term Investments

YoY Increase

YoY Decrease

Latest Year

GKOS annual cash on hand history · Cash & Short-Term Investments · Source: FMP /balance-sheet-statement

Annual cash on hand by year

GKOS cash & short-term investments history

DatePeriodCash & ST InvestmentsYoY Change

Dec 31, 2025LatestFY$278.8M-12.6%

Dec 31, 2024FY$318.9M+7.9%

Dec 31, 2023FY$295.4M-16.2%

Dec 31, 2022FY$352.7M-14.8%

Dec 31, 2021FY$414.1M+2.4%

GKOS cash on hand annual historical data · Cash & Short-Term Investments per balance sheet (10-K/10-Q) · Reported in USD · Source: FMP /balance-sheet-statement

Healthcare Sector Cash Reserves Comparison

GKOS vs peers · cash on hand

#CompanyCash & ST Inv.Market CapCash/MCapRelative

UnitedHealth Group Incorporated

Eli Lilly and Company

Glaukos CorporationYOU

GKOS

$278.8M$7B3.8%

Healthcare sector cash reserves · Source: FMP /balance-sheet-statement + /profile · Sorted by Cash desccompanies with most cash on hand →

About cash on hand & methodology

Glaukos Corporation (GKOS) cash on hand as of December 31, 2025 is $278.8M, comprising $90.8M in cash and cash equivalents (CCE) plus $187.9M in short-term investments — reported as Glaukos Corporation cash and short-term investments on the balance sheet (10-K filing). Also referred to as Glaukos Corporation cash reserves or cash position.

Glaukos Corporation annual cash on hand history shows decreased -12.6% in 2025: decreased -12.6% in 2025. Glaukos Corporation cash reserves in 2025 reflect the company's capital allocation strategy.

Glaukos Corporation carries total debt of $139.6M against cash of $278.8M, resulting in a net cash position of +$139.1M. For the full balance sheet, see the Financials → Balance Sheet tab.

Figures tie to SEC 10-K/10-Q balance sheet disclosures and FMP /balance-sheet-statement where noted.

Financial statements Free cash flow Net income Revenue Market cap P/E ratio Earnings Price history

Frequently asked questions

GKOS cash on hand · 5 questions

As of December 31, 2025, Glaukos Corporation (GKOS) has $278,760,000 in cash on hand — defined as cash and short-term investments on the balance sheet. This includes $90,813,000 in cash and cash equivalents (CCE) plus $187,947,000 in short-term investments. Latest quarter (March 31, 2026): $276,685,000. Data sourced from the annual 10-K filing via FMP.

GKOS cash on handGKOS cash reservesGKOS cash 2025how much cash does GKOS have

▸ Source: FMP /balance-sheet-statement · US GAAP · Glaukos Corporation · Glaukos Corporation SEC 10-K & 10-Q filings · US GAAP · Last updated: December 31, 2025